Telemedicine Guide
For full instructions on how to download the Healow app and start your TeleVisit, watch the video below.
Testing
Utilizing state-of-the-art medical technology, providing fast and accurate results.
Patient Information
Looking for patient resources? Find forms, policies, create a patient portal account and more here.
About DENT Neurologic Institute
Founded in 1963, DENT Neurologic Institute is the largest out-patient neurology practice in the United States. With over 70 providers among 16 sub-specialty clinics, in two convenient locations, DENT treats nearly 1,000 patients a day, amounting to over 250,000 patients a year. In addition, DENT oversees more than 75 on-going clinical research trials, eclipsing most major hospitals in the Western New York area.
DENT provides the highest quality and compassionate patient care to the Western New York region, the direct result of a tireless commitment to staying on the forefront of medical advances and breakthrough technology. By maintaining valuable partnerships with other specialized clinicians, and a dedication to employing the brightest minds in the medical and clinical research fields, you can rest assured knowing when you come to DENT you are receiving the best care possible.
Your initial visit to The DENT Cannabis Clinic is to establish a provider-patient relationship and evaluate your eligibility for the program. Find out more about our clinic.
Questions? Contact DENT today. GET IN TOUCH
What's New at DENT
Coping With Stress and the Unknown | Livestream Recap
In light of current events, Dr. Horatio Capote opened discussion on how to deal with anxiety and stress, and how working together, as a community, can benefit all of us. Anxiety Anxiety is a “perfectly normal emotion…it’s how we’re built,
To our dear friends in the Western New York community,
March 25, 2020 To our dear friends in the Western New York community, Please know that your DENT team is here for you, and remains open for all essential office, diagnostic and treatment services, including injections, infusion, imaging, and counseling.
Tepezza™ Transformation – Rodney’s Journey
On January 21, 2020, the U.S. Food and Drug Administration (FDA) approved Tepezza™ (teprotumumab-trbw) for the treatment of adults with Thyroid Eye Disease. This is a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).